OGN Organon & Co.
$13.74 +0.29%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.29%
YTD
+29.60%
P/E
17.24
P/B
2.48
ROE
23.4%
Div yield
9.9%
Beta
0.64
Market cap
$3.6B
RSI (14)
58
Next earnings
Nov 9, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$13.74
Close
$13.74
VWAP (n/a)
—
Day high
$13.75
Day low
$13.73
Volume
1.9M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference
Yahoo Finance · Oct 1
Why Organon (OGN) Is Getting Attention Today
Yahoo Finance · Sep 22
Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device
Yahoo Finance · Sep 22
PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor
Yahoo Finance · Sep 16
Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer
Yahoo Finance · Sep 1
The Surprising Pockmarks On Cooper's Earnings That Caused Its Stock To Dive
Yahoo Finance · Sep 10
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Jul 31, 2026 View → 10-Q Jul 31, 2026 View → 8-K Jul 23, 2026 View → 8-K Jul 17, 2026 View → 8-K Jun 11, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell OGN. Try it in the Lab to size a position and see the risk.